Attached files
file | filename |
---|---|
EX-99.1 - EX-99.1 - MEDICINES CO /DE | y89709exv99w1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): February 16, 2011
The Medicines Company
Delaware | 000-31191 | 04-3324394 | ||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
8 Sylvan Way Parsippany, New Jersey |
07054 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrants telephone number, including area code: (973) 290-6000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02. | Results of Operations and Financial Condition. |
On February 16, 2011, The Medicines Company (the Company) announced financial results for
the quarter and year ended December 31, 2010. The full text of the press release issued in
connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Form 8-K (including Exhibit 99.1) shall not be deemed filed for
purposes of Section 18 of the Securities Exchange Act of 1934 (the Exchange Act) or otherwise
subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any
filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by
specific reference in such a filing.
Item 9.01. | Financial Statements and Exhibits |
(c) | Exhibits | |
The following exhibit relating to Item 2.02 shall be deemed to be furnished, and not filed: |
99.1 | Press release dated February 16, 2011 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
THE MEDICINES COMPANY |
||||
Date: February 16, 2011 | By: | /s/ Paul M. Antinori | ||
Paul M. Antinori | ||||
Senior Vice President and General Counsel |
Exhibit Index
Exhibit No. | Description | |||
99.1 | Press release dated February 16, 2011 |